Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Tracheostomy

Sponsor
Aykut Saritas (Other)
Overall Status
Completed
CT.gov ID
NCT02656719
Collaborator
Prof.Dr.A.İlhan Özdemir State Hospital (Other)
80
2
13

Study Details

Study Description

Brief Summary

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound guided percutaneous tracheostomy
  • Device: Bronchoscopy guided percutaneous tracheostomy
N/A

Detailed Description

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.

Patients will be randomly assigned to be submitted to evaluate safety, complication rates, easy to perform , clinical outcomes and effectivity.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Dilatational Tracheostomy for Safety, Complications and Efficiency in Critically Ill Patient
Study Start Date :
Aug 1, 2015
Actual Primary Completion Date :
Sep 1, 2016
Actual Study Completion Date :
Sep 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ultrasound

Ultrasound guided percutaneous tracheostomy

Device: Ultrasound guided percutaneous tracheostomy
Ultrasound guided percutaneous tracheostomy

Active Comparator: Bronchoscopy

Bronchoscopy guided percutaneous tracheostomy

Device: Bronchoscopy guided percutaneous tracheostomy
Bronchoscopy guided percutaneous tracheostomy

Outcome Measures

Primary Outcome Measures

  1. procedure failure of ultrasound to provide this anatomical information and ease of perform [During percutaneous tracheostomy an expected average time 20 minutes]

    occurence of a major complications: bleeding, subcutaneous emphysema, oesophageal perforation, number of applied needle interventions, procedure duration, cardiorespiratory arrest

Secondary Outcome Measures

  1. procedure time [during percutaneous tracheostomy ( average expected time 20 minutes)]

    the procedure duration was taken as the time that elapsed from the placement of the needle to the placement of the tracheostomy cannula.

  2. Pneumothorax [Participants will be followed for the duration of hospital stay, an expected average of 4 weeks]

    Pneumothorax due to the percutaneous tracheostomy detected by clinical examination during the procedure or chest x-ray after the procedure.

  3. Tracheal posterior wall injury [Participants will be followed for the duration of hospital stay, an expected average of 4 weeks]

    Tracheal posterior wall injury as detected by bronchoscopy after the procedure

  4. Accidental decannulation [Participants will be followed for the duration of hospital stay, an expected average of 4 weeks]

    Accidental decannulation after the procedure during Hospital stay

  5. Cardiorespiratory arrest [during percutaneous tracheostomy an expected average of 20 minutes]

    Cardiorespiratory arrest due to percutaneous tracheostomy

  6. Minor bleeding [Participants will be followed for the duration of hospital stay, an expected average of 4 weeks]

    Haemorrhage that could not be stopped by sponge wrapping the stoma after the procedure and/or blood coming with aspiration inside the tracheostomy tube was defined as minor bleeding

  7. Major bleeding [During the procedure an expected average of 20 minutes]

    Continuous haemorrhage from the stoma and/or from the trachea with aspiration despite compresses was defined as a major haemorrhage.

Other Outcome Measures

  1. Hypoxemia [During percutaneous tracheostomy an expected average of 20 minutes]

    Drop in peripheral oxygen saturation < 90% for more than 2 minutes as measured by pulse oximeter during the procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All intubated and mechanically ventilated patients indicated for a tracheostomy
Exclusion Criteria:
  • Patients with tracheal or neck abnormalities, soft tissue infection in the neck, neck surgery history, oxygenation problems , coagulation disorders or coagulation parameter changes and those requiring urgent or surgery patients unable to provide informed consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Aykut Saritas
  • Prof.Dr.A.İlhan Özdemir State Hospital

Investigators

  • Principal Investigator: Aykut Saritas, MD, İzmir Tepecik Training and Research Hospital
  • Study Chair: muhammed murat kurnaz, MD, Prof.Dr.A.İlhan Ozdemir State hospital Giresun

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Aykut Saritas, principal investigator, Tepecik Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT02656719
Other Study ID Numbers:
  • 2014-1
First Posted:
Jan 15, 2016
Last Update Posted:
Mar 10, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Aykut Saritas, principal investigator, Tepecik Training and Research Hospital

Study Results

No Results Posted as of Mar 10, 2020